Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation TCT 2025

European Transition from Medical Device Director (MDD) to Medical Device Regulation (MDR): Roadmap for the Future of Global AF Studies

Presenter: Philippe PM Garot

October 28, 2025

Presentation TCT 2025

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

Presenter: Robert T. Gerber

October 27, 2025

Presentation TCT 2025

TCT 1934: Fully Percutaneous Thrombectomy for Clot-in-Transit Across a Patent Foramen Ovale in Massive Pulmonary Embolism

Presenter: Matteo Sturla

October 26, 2025

Presentation TCT 2025

Timing the Transition: Hemodynamic Decompensation and MCS Candidacy in Heart Failure

Presenter: Cate Enstrom

October 25, 2025

Presentation TCT 2024

Wound Care Transition – Holistic Care for Transition from Inpatient to Outpatient

Presenter: Kimberly Campbell

October 27, 2024

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

Presentation TCT 2023

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

Presenter: Mohammad Akram Kawsara

October 25, 2023

Presentation TCT 2023

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

Presenter: Mouzam Faroqui

October 25, 2023

Presentation TCT 2023

How to Become/Be Successful As a Cath Lab Director

Presenter: Herbert Aronow

October 25, 2023

Presentation TCT 2023

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

Presenter: Steven Farmer

October 24, 2023

Presentation TCT 2023

TCT 601: In-Hospital Outcomes of IVUS-Guided PCI Versus Angiography-Guided PCI: Is the Transition to Higher IVUS Utilization Improving Patient Outcomes?

Presenter: Daniel Lutz

October 24, 2023

Presentation TCT 2023

Transitional Coverage for Emerging Technologies (TCET): Stimulant for Innovations

Presenter: Steven Farmer

October 23, 2023

Presentation TCT 2022

R Sided Clot in Transit

Presenter: Matthew Finn

September 19, 2022

Presentation TCT 2022

Case 2: COVID Patient With Clot in Transit

Presenter: Matthew Finn

September 18, 2022

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

Presentation TCT 2020

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Presenter: Jennifer Rymer

October 14, 2020

Presentation TCT 2019

Transitioning to Monotherapy in Patients After PCI

Presenter: Pascal Vranckx

September 26, 2019

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Early Insights from Industry

Presenter: Charles J. Davidson, Nicole Ibrahim, Dan Mans

October 30, 2016

Presentation TCT 2016

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Presenter: Charles J. Davidson, Nicole Ibrahim, Paul Sorajja

October 30, 2016

Advertisement

European Transition from Medical Device Director (MDD) to Medical Device Regulation (MDR): Roadmap for the Future of Global AF Studies

TCT 945: The TASMAN Study: Third (3G) Alongside Second (2G) Generation Drug Eluting Stent (DES) and overall MACCE At Nepean: Insights from a large west of Sydney Tertiary centre during the Transition from 2G to 3G DES.

TCT 1934: Fully Percutaneous Thrombectomy for Clot-in-Transit Across a Patent Foramen Ovale in Massive Pulmonary Embolism

Timing the Transition: Hemodynamic Decompensation and MCS Candidacy in Heart Failure

Wound Care Transition – Holistic Care for Transition from Inpatient to Outpatient

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

TCT 945: Conform WhenThings are Unconformable: Novel Utilization of Combined Thrombectomy Devices to remove a Massive Organized Clot-in-Transit

TCT 944: Sucessful Aspiration of Saddle Pulmonary Embolism and Thrombus in Transit via PFO

How to Become/Be Successful As a Cath Lab Director

Status Update on the Breakthrough Device Transitional Coverage for Emerging Technologies Program (TCET)

TCT 601: In-Hospital Outcomes of IVUS-Guided PCI Versus Angiography-Guided PCI: Is the Transition to Higher IVUS Utilization Improving Patient Outcomes?

Transitional Coverage for Emerging Technologies (TCET): Stimulant for Innovations

R Sided Clot in Transit

Case 2: COVID Patient With Clot in Transit

TRANSIT: Treatment of Failed TAVR With TAVR

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Transitioning to Monotherapy in Patients After PCI

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

TMVR Clinical Trial Design: Early Insights from Industry

TMVR Clinical Trial Design: Similarities and Differences -TAVR and Transcatheter Mitral Therapy Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content